Global Lab Automation Market Set To Grow To $6.3bn By 2022

02 August 2018
Pharma

Visiongain’ has launched a new pharma report Global Lab Automation Market Forecast 2018-2028: Modular Automation, Total Lab Automation, Automated Liquid Handling, Microplate Readers, Software & Informatics, Automated Storage & Retrieval Systems, Automated Integrated Workstations, Reagent Dispensers, Microplate Washers, Multi-mode, Single-mode, Laboratory Information Management System, Electronic Laboratory Notebook, Scientific Data Management Systems, Drug Discovery, Clinical Diagnostics, Genomic Solutions, Proteomic Solutions, Others

Laboratory automation system includes automated lab instruments, software and devices which offer benefits such as reduction of cycle time, increasing productivity, improvement of workflow coverage and improvement of data quality. The laboratory automation or robotic products are offered in modified form, according to the necessity of specific laboratories or researcher. Therefore, lab automation becomes essential in laboratories for handling high volumes of sample at faster rate. This system offers smooth solution to lab procedures such as decapping, centrifugation, aliquoting, recapping and sorting among others.

The lead analyst of the report commented “In 2017, the automated liquid handling submarket held the largest market share in the global lab automation market. Growth in this market is set to be driven by the precision and accuracy offered, reduced cost of labour and the availability of a wide range of application.

The microplate readers submarket is expected to grow at the highest CAGR in the forecast period from 2018 to 2028. The growth of this submarket is driven by ease of use, as well as combination of multiple measurement technologies such as absorbance, fluorescence, and luminescence into one compact instrument.”

Leading companies featured in the report include Danaher Corporation, Thermo Fisher Scientific, Inc., Roche Holding AG, Siemens Healthineers, Qiagen N.V., PerkinElmer, Inc., Agilent Technologies, Abbott Laboratories, Tecan Trading AG, Labcyte, Inc.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“The colon targeting drug delivery market will grow with exponential growth of 14% over the forecast period from 2020-2030”, says Visiongain

The colon targeting drug delivery market has been used various polymers including biodegradable polymers, guar gum, pectin, chondroitin sulfate, dextran, chitosan, cyclodextrin, inulin, amylose, locust bean gum, and others

23 September 2019

Read

“Global Diagnostic Imaging market set to grow to $32bn by 2024” says Visiongain report

Diagnostic imaging technology such as MRI and CT scans has become more precise and accessible, due to which radiology has increasingly become a key foundation of modern medicine.

20 September 2019

Read

“Oncology remains the largest disease area in the pharmaceutical business. The oncology market is dominated by big pharma companies and high price labels” says Visiongain report

Although price is still the most important competitive advantage for a biosimilar company, current discount rates are not enough to automatically convince the key stakeholders of a biosimilar’s value.

10 September 2019

Read

“Anti-Infective Agents market set to grow to $141bn by 2024” says new Visiongain report

The global anti-infective agents market is one that is driven by innovation. This is vital for maintaining the rich pipeline of anti-infective agents seen in the market today.

09 September 2019

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever
Do NOT follow this link or you will be banned from the site!